about
PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma.The need for improved brain lesion segmentation techniques for children with cerebral palsy: A review.Automated, quantitative measures of grey and white matter lesion burden correlates with motor and cognitive function in children with unilateral cerebral palsyEarly prediction of treatment response in advanced gliomas with (18)F-dopa positron-emission tomographyHypoxia imaging in gliomas with 18F-fluoromisonidazole PET: toward clinical translation.Hashed nonlocal means for rapid image filtering.Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.Federated optimisation of kinetic analysis problems.Optical differentiation between malignant and benign lymphadenopathy by grey scale texture analysis of endobronchial ultrasound convex probe images.Grey scale texture analysis of endobronchial ultrasound mini probe images for prediction of benign or malignant aetiology.Optimization of MRI-based scoring scales of brain injury severity in children with unilateral cerebral palsy.Modelling of FDG metabolism in liver voxels.Alterations in regional shape on ipsilateral and contralateral cortex contrast in children with unilateral cerebral palsy and are predictive of multiple outcomes.Using ventricular modeling to robustly probe significant deep gray matter pathologies: Application to cerebral palsy.Robust inverse-consistent affine CT-MR registration in MRI-assisted and MRI-alone prostate radiation therapy.Development of an automated measure of iliac artery tortuosity that successfully predicts early graft-related complications associated with endovascular aneurysm repair.Estimating the joint statistics of images using nonparametric windows with application to registration using mutual information.Dual acquisition of (18)F-FMISO and (18)F-FDOPA.Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patientsAmorphous regions-of-interest projection method for simplified longitudinal comparison of dynamic regions in cancer imagingValproate in Adjuvant Glioblastoma Treatment
P50
Q35466938-F49814C0-F7AC-4717-A9E8-8EDBB319D66EQ35783667-7538C68A-1895-4029-B747-E33ECC585720Q37005415-5A85125C-516D-40E1-A01D-4E1D73CE53F7Q37577677-0D1459AC-D12D-48E0-AC7E-E8D280580B0AQ38364006-BA7DD0E0-46FB-4183-9040-38F7A601686BQ38431545-FFDAEF50-85C0-4CE5-9629-1265CCA6D34AQ38544974-2A509F1E-F365-46AD-9D1A-589BA582D843Q39648938-A78F1301-B3D2-4F85-8812-77B24FB6A14DQ39997177-1B4DF988-6941-46FD-8D4C-DD96B70A07E9Q40291564-F732E779-E6D5-4619-AA97-319F9638E534Q40329369-69AC54A3-62F1-40EF-B225-9688C8D4F7CFQ41753312-6A6D3429-E083-4751-83AE-95339F19F83DQ48695954-3C4265D7-A143-4D3A-B22E-8F55817AE885Q48696572-1078346C-F3CB-49DD-89AC-B08DFCB4A3DAQ50916459-1F18A27D-E295-4782-B4AA-CD255679813AQ51076486-2AA581D8-97E6-4122-9C0A-5E7B9ED02814Q51871214-5AC7801C-8C30-4A17-B300-B33CE9261E65Q53062011-9660950D-6C8F-4FC1-8074-FE8B79F7E0A6Q85108387-C0024C5E-2793-4ED3-9A5D-ACF2514BC909Q85969385-4D7D7AD3-AFBC-49B4-B417-EB6937B8C712Q87660023-B3A097BB-6CE0-418C-9C6B-F9F670D52EA5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicholas Dowson
@ast
Nicholas Dowson
@en
Nicholas Dowson
@es
Nicholas Dowson
@nl
Nicholas Dowson
@sl
type
label
Nicholas Dowson
@ast
Nicholas Dowson
@en
Nicholas Dowson
@es
Nicholas Dowson
@nl
Nicholas Dowson
@sl
prefLabel
Nicholas Dowson
@ast
Nicholas Dowson
@en
Nicholas Dowson
@es
Nicholas Dowson
@nl
Nicholas Dowson
@sl
P106
P21
P2456
P31
P496
0000-0003-4694-5459